Terminated PHASE3 INTERVENTIONAL NCT00091156

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

A Randomized Phase III Study of Follow Up With or Without Adjuvant Gefitinib (Iressa™) Following Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Lung Cancer

Interventions adjuvant therapy gefitinib

Updated 6 times since 2017 Last updated: Jul 13, 2012 Started: May 31, 2004 Primary completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

low accrual

Other terminated trials from European Organisation for Research and Treatment of Cancer - EORTC

See all terminations from European Organisation for Research and Treatment of Cancer - EORTC

Other Lung Cancer trials with similar outcome

Browse all Lung Cancer trials

A PHASE3 clinical study on Lung Cancer, this trial is terminated or withdrawn. The trial is conducted by European Organisation for Research and Treatment of Cancer - EORTC and has accumulated 6 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

May 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Organisation for Research and Treatment of Cancer - EORTC

Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

's-Hertogenbosch, Netherlands , Antwerp, Belgium , Arnhem, Netherlands , Bergamo, Italy , Cairo, Egypt , Cuneo, Italy , Ferrara, Italy , Ghent, Belgium , Haarlem, Netherlands , Leiden, Netherlands and 17 more locations